Literature DB >> 21092441

[An antimicrobial resistance surveillance of gram-positive cocci isolated from 12 teaching hospitals in China in 2009].

Hong-li Sun1, Hui Wang, Min-jun Chen, Ying-mei Liu, Zhi-dong Hu, Kang Liao, Yun-zhuo Chu, Jin-e Lei, Bing Zhang, Yun-song Yu, Bi-jie Hu, Zi-yong Sun, Zheng Zhang, Qi-yong He.   

Abstract

OBJECTIVE: To investigate antimicrobial resistance among gram-positive cocci in China in 2009.
METHODS: From June to December 2009, 1169 consecutive and non-repetitive gram-positive cocci were collected from 12 teaching hospitals at 9 cities. The minimal inhibitory concentration (MIC) of antibacterial agents was determined by agar dilution method.
RESULTS: The prevalences of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative Staphylococci (MRCoNS) were 45.3% (211/466) and 89.5% (214/239), respectively. The isolation rate of MRSA was 33.3% - 68.1% from different samples. All Staphylococci isolates were susceptible to vancomycin, teicoplanin and linezolid. Five point five percent (7/128) E.faecium strains were resistant to vancomycin. All E. faecalis strains were susceptible to vancomycin. About 99.1% (108/109) of E.faecalis and E.faecium were susceptible to linezolid. The prevalence of penicillin-intermediate Streptococcus pneumoniae (PISP) was 21.6% (48/222). Only 1 (0.5%, 1/222) Streptococcus pneumoniae strain was resistant to penicillin. Teicoplanin, vancomycin, linezolid and tigecycline were the most active agents against Streptococcus pneumoniae (susceptible rate 100%).
CONCLUSIONS: The high prevalence of methicillin-resistance is among Staphylococcus strains. Different samples show a different MRSA prevalence. Teicoplanin, vancomycin and linezolid show very high activity to Staphylococci, E. faecalis, E. faecium and Streptococcus pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21092441

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  4 in total

1.  Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China.

Authors:  Ya-Fen Liu; Yan Gao; Mei-Fang Chen; Bin Cao; Xiao-Hua Yang; Lai Wei
Journal:  BMC Infect Dis       Date:  2013-07-09       Impact factor: 3.090

Review 2.  Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance.

Authors:  Dan Cui; Xinliang Liu; Peter Hawkey; Hao Li; Quan Wang; Zongfu Mao; Jing Sun
Journal:  J Int Med Res       Date:  2017-01-30       Impact factor: 1.671

3.  Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017.

Authors:  Lin Huang; Rong Zhang; Yanyan Hu; Hongwei Zhou; Junmin Cao; Huoyang Lv; Shi Chen; Shibiao Ding; Gongxiang Chen
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-30       Impact factor: 4.887

Review 4.  Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of China.

Authors:  Beth Lesher; Xin Gao; Yixi Chen; Zhengyin Liu
Journal:  Clinicoecon Outcomes Res       Date:  2016-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.